D-Index & Metrics Best Publications
Medicine
Denmark
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 107 Citations 51,065 452 World Ranking 3632 National Ranking 39

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Denmark Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Internal medicine

His scientific interests lie mostly in Cancer research, Gene expression, Cancer, Bladder cancer and Internal medicine. His work deals with themes such as DNA methylation, Carcinogenesis, Cancer cell, Cell cycle and Gene silencing, which intersect with Cancer research. His Gene expression study results in a more complete grasp of Gene.

His research in Cancer tackles topics such as microRNA which are related to areas like DNA microarray. His Bladder cancer research also works with subjects such as

  • Pathology which connect with Urothelium, Urinary bladder, Colorectal cancer and S100 Calcium Binding Protein A7,
  • Mutation together with Chromatin. He combines subjects such as Genetic model, Diabetes mellitus, Endocrinology and Oncology with his study of Internal medicine.

His most cited work include:

  • Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets (4665 citations)
  • DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (2235 citations)
  • Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints (1500 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Cancer research, Pathology, Bladder cancer and Cancer. His Internal medicine study combines topics in areas such as Endocrinology and Oncology. Torben F. Ørntoft has included themes like Methylation, Carcinogenesis, Cancer cell, microRNA and Gene silencing in his Cancer research study.

The concepts of his Pathology study are interwoven with issues in Urothelium, Gene expression and Antigen. His Bladder cancer study deals with Urine intersecting with Urology and Cystoscopy. His biological study spans a wide range of topics, including Stage and Immunology.

He most often published in these fields:

  • Internal medicine (30.38%)
  • Cancer research (24.26%)
  • Pathology (24.26%)

What were the highlights of his more recent work (between 2015-2020)?

  • Internal medicine (30.38%)
  • Oncology (21.10%)
  • Prostate cancer (14.77%)

In recent papers he was focusing on the following fields of study:

Torben F. Ørntoft focuses on Internal medicine, Oncology, Prostate cancer, Cancer and Bladder cancer. His Oncology research is multidisciplinary, relying on both Bioinformatics, Disease, Cohort, Pathology and microRNA. His study in the field of Biopsy also crosses realms of Cell-free fetal DNA.

His Cancer research incorporates elements of Mutation and Gene. His Bladder cancer research includes themes of Exome sequencing, Progressive disease, Cancer research and Metastasis. The various areas that he examines in his Cancer research study include Regulation of gene expression and Gene silencing.

Between 2015 and 2020, his most popular works were:

  • Direct detection of early-stage cancers using circulating tumor DNA (420 citations)
  • Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma (269 citations)
  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (268 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Torben F. Ørntoft mainly investigates Bladder cancer, Internal medicine, Oncology, Disease and Cancer research. His studies in Bladder cancer integrate themes in fields like Mutation, Urine and Urology. His Oncology research is multidisciplinary, incorporating elements of Prostate cancer and Genetic association.

His Disease study is concerned with the field of Pathology as a whole. His Pathology study combines topics in areas such as Biomarker, Colorectal cancer and Digital polymerase chain reaction. He combines subjects such as Cancer, Bioinformatics, Transcriptome, microRNA and Gene silencing with his study of Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets

Claus Lindbjerg Andersen;Jens Ledet Jensen;Torben Falck Ørntoft.
Cancer Research (2004)

8317 Citations

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

Jirina Bartkova;Zuzana Horejsí;Karen Koed;Alwin Krämer.
Nature (2005)

3051 Citations

Genome-wide association study identifies five new schizophrenia loci

Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson.
Nature Genetics (2011)

2508 Citations

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Jirina Bartkova;Nousin Rezaei;Michalis Liontos;Panagiotis Karakaidos.
Nature (2006)

2088 Citations

Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH.

Oliver M Sieber;Lara Lipton;Michael Crabtree;Karl Heinimann.
The New England Journal of Medicine (2003)

1063 Citations

Direct detection of early-stage cancers using circulating tumor DNA

Jillian Phallen;Mark Sausen;Vilmos Adleff;Alessandro Leal.
Science Translational Medicine (2017)

724 Citations

Identifying distinct classes of bladder carcinoma using microarrays

Lars Dyrskjøt;Thomas Thykjaer;Mogens Kruhøffer;Jens Ledet Jensen.
Nature Genetics (2003)

690 Citations

Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer

Troels Schepeler;Jørgen T. Reinert;Marie S. Ostenfeld;Lise L. Christensen.
Cancer Research (2008)

593 Citations

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

Lars Dyrskjøt;Mogens Kruhøffer;Thomas Thykjaer;Niels Marcussen.
Cancer Research (2004)

587 Citations

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch.
Nature Genetics (2018)

540 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Torben F. Ørntoft

Decio L. Eizirik

Decio L. Eizirik

Université Libre de Bruxelles

Publications: 120

Ole A. Andreassen

Ole A. Andreassen

Oslo University Hospital

Publications: 112

Thomas Werge

Thomas Werge

University of Copenhagen

Publications: 103

Anders D. Børglum

Anders D. Børglum

Aarhus University

Publications: 102

Stephan Ripke

Stephan Ripke

Massachusetts General Hospital

Publications: 94

Ole Mors

Ole Mors

Aarhus University

Publications: 93

Audrey Goddard

Audrey Goddard

Gilead Sciences

Publications: 92

Graham G. Giles

Graham G. Giles

University of Melbourne

Publications: 90

Vassilis G. Gorgoulis

Vassilis G. Gorgoulis

National and Kapodistrian University of Athens

Publications: 88

Rosalind A. Eeles

Rosalind A. Eeles

Institute of Cancer Research

Publications: 87

Patrick F. Sullivan

Patrick F. Sullivan

University of North Carolina at Chapel Hill

Publications: 84

Paul J. Godowski

Paul J. Godowski

Genentech

Publications: 84

David M. Hougaard

David M. Hougaard

Statens Serum Institut

Publications: 81

Preben Bo Mortensen

Preben Bo Mortensen

Aarhus University

Publications: 80

Jiri Bartek

Jiri Bartek

Science for Life Laboratory

Publications: 76

Michael Conlon O'Donovan

Michael Conlon O'Donovan

Cardiff University

Publications: 72

Trending Scientists

Suckchel Yang

Suckchel Yang

Soongsil University

Goksen G. Yaralioglu

Goksen G. Yaralioglu

Özyeğin University

Colin Bailey

Colin Bailey

Queen Mary University of London

Nicholas Zabaras

Nicholas Zabaras

University of Notre Dame

Willy Tinner

Willy Tinner

University of Bern

Yoshinori Moriyama

Yoshinori Moriyama

Okayama University

Paul M. Mathews

Paul M. Mathews

New York University

Hamid Band

Hamid Band

University of Nebraska Medical Center

Helmut Wachter

Helmut Wachter

University of Innsbruck

Tarmo Soomere

Tarmo Soomere

Tallinn University of Technology

Suzanne Hidi

Suzanne Hidi

University of Toronto

Jean Burgess

Jean Burgess

Queensland University of Technology

David R. Heise

David R. Heise

Indiana University

Tony Bennett

Tony Bennett

Western Sydney University

Peter B. Littlewood

Peter B. Littlewood

University of Chicago

Maryvonne Gerin

Maryvonne Gerin

École Normale Supérieure

Something went wrong. Please try again later.